Baby stem cells injected to fix failing hearts in kids and young adults

NCT ID NCT06464588

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial tests whether infusions of stem cells from donated newborn tissue are safe for young people aged 4 to 39 with dilated cardiomyopathy, a condition where the heart becomes enlarged and weak. Up to 36 participants will receive three intravenous doses over 30 days. Researchers will monitor for serious side effects and measure changes in heart function over a year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
neonatal mesenchymal stromal cells (nMSCs)
What this could lead to
If safe and effective, this could point toward a new treatment to improve heart function in people with dilated cardiomyopathy.
What could go wrong
This is a very early phase 1 trial with only 36 participants, focused on safety. It may not show clear benefit, and there are risks of severe side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DILATED CARDIOMYOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Arthur M. Blank Hospital

    RECRUITING

    Atlanta, Georgia, 30329, United States

  • Emory University Hospital

    RECRUITING

    Atlanta, Georgia, 30322, United States

  • Grady Memorial Hospital

    RECRUITING

    Atlanta, Georgia, 30303, United States

  • Hughes Spalding Children's Hospital

    RECRUITING

    Atlanta, Georgia, 30303, United States

  • Scottish Rite Children's Hospital

    RECRUITING

    Atlanta, Georgia, 30342, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.